KPIs & Operating Metrics(New)
Adjusted Ebitda By SegmentAdjusted Ebitda By Segment AnnualAdjusted Ebitda Margin By Segment %Adjusted Ebitda Margin By Segment Annual %Assets By Segment AnnualBreakdown Of AssetsClinics In Active DevelopmentCost Of Revenue BreakdownDeferred RevenueEmployee StatisticsFranchise License Sold AnnualFranchise License Sold AnnuallyGross Margin %Gross ProfitNew Patients Treated AnnualNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Operating Income (Loss) By SegmentOperating Income (Loss) By Segment AnnualOperating Margin By Segment %Operating Margin By Segment Annual %Opex As A % Of Total Revenue %OPEX SegregationPatient Visits AnnualProperty And Equipment, Net BreakdownRemaining Performance Obligations AnnualRevenue By Business VerticalRevenue By Business Vertical %Revenue By Business Vertical AnnualRevenue By Business Vertical Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %Revenue By Timing Of Transfer Of ServicesRevenue By Timing Of Transfer Of Services %Revenue By Timing Of Transfer Of Services AnnualRevenue By Timing Of Transfer Of Services Annual %Total Clinics In Operation At The End Of The Period
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Joint (JYNT) Gross Profit (2016 - 2025)

Historic Gross Profit for Joint (JYNT) over the last 13 years, with Q3 2025 value amounting to $10.6 million.

  • Joint's Gross Profit rose 737.0% to $10.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $41.5 million, marking a year-over-year increase of 806.81%. This contributed to the annual value of $40.6 million for FY2024, which is 1137.02% up from last year.
  • Joint's Gross Profit amounted to $10.6 million in Q3 2025, which was up 737.0% from $9.8 million recorded in Q2 2025.
  • In the past 5 years, Joint's Gross Profit ranged from a high of $22.9 million in Q3 2022 and a low of -$22.3 million during Q4 2022
  • Its 5-year average for Gross Profit is $11.4 million, with a median of $9.9 million in 2023.
  • Its Gross Profit has fluctuated over the past 5 years, first plummeted by 23972.25% in 2022, then soared by 14433.22% in 2023.
  • Over the past 5 years, Joint's Gross Profit (Quarter) stood at $15.9 million in 2021, then crashed by 239.72% to -$22.3 million in 2022, then soared by 144.33% to $9.9 million in 2023, then increased by 16.83% to $11.5 million in 2024, then fell by 8.37% to $10.6 million in 2025.
  • Its last three reported values are $10.6 million in Q3 2025, $9.8 million for Q2 2025, and $9.6 million during Q1 2025.